Autor: "Morgan, Jeffrey A." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.
Autorzy:: Choy E; Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA, USA. .
Butrynski JE
Harmon DC
Morgan JA
George S
Wagner AJ
D'Adamo D
Cote GM
Flamand Y
Benes CH
Haber DA
Baselga JM
Demetri GD; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2014 Nov 05; Vol. 14, pp. 813. Date of Electronic Publication: 2014 Nov 05.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Bone Neoplasms/*drug therapy
Phthalazines/*therapeutic use
Piperazines/*therapeutic use
Sarcoma, Ewing/*drug therapy
Adolescent ; Adult ; Aged ; Antineoplastic Agents/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bone Neoplasms/mortality ; Bone Neoplasms/pathology ; Combined Modality Therapy ; Female ; Humans ; Male ; Middle Aged ; Phthalazines/pharmacology ; Piperazines/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors ; Retreatment ; Sarcoma, Ewing/mortality ; Sarcoma, Ewing/pathology ; Treatment Failure ; Treatment Outcome ; Young Adult

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
Autorzy:: Demetri GD; Ludwig Center at Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA. />van Oosterom AT
Garrett CR
Blackstein ME
Shah MH
Verweij J
McArthur G
Judson IR
Heinrich MC
Morgan JA
Desai J
Fletcher CD
George S
Bello CL
Huang X
Baum CM
Casali PG; Pokaż więcej
Źródło:: Lancet (London, England) [Lancet] 2006 Oct 14; Vol. 368 (9544), pp. 1329-38.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Gastrointestinal Stromal Tumors/*drug therapy
Indoles/*therapeutic use
Piperazines/*therapeutic use
Protein Kinase Inhibitors/*therapeutic use
Pyrimidines/*therapeutic use
Pyrroles/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Benzamides ; Double-Blind Method ; Female ; Gastrointestinal Stromal Tumors/mortality ; Gastrointestinal Stromal Tumors/pathology ; Humans ; Imatinib Mesylate ; Indoles/adverse effects ; Male ; Middle Aged ; Piperazines/adverse effects ; Protein Kinase Inhibitors/adverse effects ; Pyrimidines/adverse effects ; Pyrroles/adverse effects ; Sunitinib ; Survival Analysis ; Treatment Outcome

Czasopismo naukowe

Skocz do pozycji: 3.

Tytuł:: Gemcitabine and Vinorelbine Combination Chemotherapy for Patients With Advanced Soft Tissue Sarcomas.
Autorzy:: Dileo, Palma
Morgan, Jeffrey A.
Zahrieh, David
Desai, Jayesh
Salesi, Jeanine M.
Harmon, David C.
Quigley, M. Travis
Polson, Kathleen
Demetri, George D.
George, Suzanne; Pokaż więcej
Temat:: SOFT tissue tumors
SARCOMA
VINORELBINE
ANTINEOPLASTIC agents
CANCER treatment
PATIENTS
Źródło:: Cancer (0008543X); May2007, Vol. 109 Issue 9, p1863-1869, 7p, 3 Charts, 2 Graphs

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4.

Tytuł:: A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas.
Autorzy:: Cote, Gregory M. (AUTHOR)
Choy, Edwin (AUTHOR)
Chen, Tianqi (AUTHOR)
Marino-Enriquez, Adrian (AUTHOR)
Morgan, Jeffrey (AUTHOR)
Merriam, Priscilla (AUTHOR)
Thornton, Katherine (AUTHOR)
Wagner, Andrew J. (AUTHOR)
Nathenson, Michael J. (AUTHOR)
Demetri, George (AUTHOR)
George, Suzanne (AUTHOR); Pokaż więcej
Źródło:: European Journal of Cancer. Feb2020, Vol. 126, p21-32. 12p.

Czasopismo naukowe

Szczegóły

Informacja